Alpha Tau Medical (DRTS) Treasury Shares (2020 - 2025)
Alpha Tau Medical (DRTS) posted quarterly Treasury Shares of $747506.0 for Q4 2025, down 12.87% year-on-year from $857899.0 in Q4 2024, and down 38.28% on a QoQ basis from $1.2 million in Q2 2025.
Alpha Tau Medical (DRTS) Treasury Shares (2020 - 2025) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Treasury Shares for 6 consecutive years, with $747506.0 the latest figure, recorded in Q4 2025.
- Quarterly Treasury Shares fell 12.87% year-over-year to $747506.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $747506.0 (down 12.87% YoY) and the FY2025 annual result came in at $747506.0, down 12.87% from the prior year.
- Treasury Shares slipped to $747506.0 in Q4 2025 per DRTS's latest filing, from $1.2 million in the prior quarter.
- Over the last five years, Treasury Shares for DRTS reached as high as $13.7 million in Q4 2021 and fell as low as $747506.0 in Q4 2025.
- A 5-year average of $2.8 million and a median of $924867.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares soared 90.03% — and 2022, when it plunged 93.27%.
- Year by year, Treasury Shares stood at $13.7 million in 2021, then tumbled by 93.27% to $924867.0 in 2022, then declined by 12.07% to $813268.0 in 2023, then gained by 5.49% to $857899.0 in 2024, then declined by 12.87% to $747506.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $747506.0, $1.2 million, and $857899.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Alpha Tau Medical | 1.19 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 747,506.00 |
| Dec 31, 2025 | 747,506.00 |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Dec 31, 2024 | 857,899.00 |
| Dec 31, 2024 | 857,899.00 |
| Dec 31, 2023 | 813,268.00 |
| Dec 31, 2023 | 813,268.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Dec 31, 2022 | 924,867.00 |
| Dec 31, 2022 | 924,867.00 |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2020 | 7.23 Mn |
| Dec 31, 2020 | 7.23 Mn |